Welcome to kongre.net
Speaker
Chief Technology Officer, Ripple Therapeutics
Wendy Naimark, Chief Technology Officer at Ripple Therapeutics, is speaking at 10th Complement-Based Drug Development Summit (Boston, United States of America, 8–10 Dec 2026) in the session “Intravitreal Complement Factor B Inhibition for Geographic Atrophy: RTC-4202, an Epidel®-Based Sustained-Release Implant Targeting Factor B”.
8–10 Dec 2026Boston, United States of America
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Wendy Naimark, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].